Non-alcoholic Steatohepatitis and Cancer

Ferlay, 2001 Bosch, 2004, Primary liver cancer: worldwide incidence and trends, Gastroenterology, 127, S5, 10.1053/j.gastro.2004.09.011 El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001 El-Serag, 2000, Risk factors for the rising rates of primary liver cancer in the United States, Arch Intern Med, 160, 3227, 10.1001/archinte.160.21.3227 Di Bisceglie, 2003, Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status, Am J Gastroenterol, 98, 2060, 10.1016/S0002-9270(03)00552-5 Dyer, 2005, Review article: the changing epidemiology of hepatocellular carcinoma in Canada, Aliment Pharmacol Ther, 22, 17, 10.1111/j.1365-2036.2005.02504.x Liang, 1993, Viral pathogenesis of hepatocellular carcinoma in the United States, Hepatology, 18, 1326 McCullough, 2004, The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease, Clin Liver Dis, 8, 521, 10.1016/j.cld.2004.04.004 Bugianesi, 2004, Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?, Dig Liver Dis, 36, 165, 10.1016/j.dld.2003.12.008 Bugianesi, 2002, Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168 Marrero, 2002, NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States, Hepatology, 36, 1349, 10.1053/jhep.2002.36939 Ratziu, 2002, Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis, Hepatology, 35, 1485, 10.1053/jhep.2002.33324 Regimbeau, 2004, Obesità and diabetes as a risk factor for hepatocellular carcinoma, Liver Transpl, 10, S69, 10.1002/lt.20033 Powell, 1990, The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114 Poonawala, 2000, Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study, Hepatology, 32, 689, 10.1053/jhep.2000.17894 1994, Italian Multicentre Cooperative project on nutrition in liver cirrhosis. Nutritional status in cirrhosis, J Hepatol, 21, 317, 10.1016/S0168-8278(05)80308-3 Mofrad, 2003, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values, Hepatology, 37, 1286, 10.1053/jhep.2003.50229 Cotrim, 2000, Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?, Am J Gastroenterol, 95, 3018, 10.1111/j.1572-0241.2000.03241.x Zen, 2001, Hepatocellular carcinoma arising in non-alcoholic steatohepatitis, Pathol Int, 51, 127, 10.1046/j.1440-1827.2001.01174.x Orikasa, 2001, Lipid-rich clear cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus, J Submicrosc Cytol Pathol, 35, 195 Shimada, 2002, Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, J Hepatol, 37, 154, 10.1016/S0168-8278(02)00099-5 Mori, 2004, Hepatocellular carcinoma with nonalcoholic steatohepatitis, J Gastroenterol, 39, 391, 10.1007/s00535-003-1308-3 Bullock, 2004, Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma, J Hepatol, 41, 685, 10.1016/j.jhep.2004.05.008 Yoshioka, 2004, Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma and burn-out NASH, J Gastroenterol, 39, 1215, 10.1007/s00535-004-1475-x Sato, 2005, Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid, Virchows Arch, 447, 996, 10.1007/s00428-005-0042-z Ikeda, 2006, Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder, Pathol Int, 56, 40, 10.1111/j.1440-1827.2006.01916.x Fassio, 2004, Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies, Hepatology, 40, 820 Harrison, 2003, The natural history of nonalcoholic fatty liver disease: a clinical histopathological study, Am J Gastroenterol, 98, 2042, 10.1111/j.1572-0241.2003.07659.x Hui, 2003, Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C, Hepatology, 38, 420, 10.1053/jhep.2003.50320 Adams, 2005, The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014 Caldwell, 2004, The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease, J Hepatol, 40, 578, 10.1016/j.jhep.2004.02.013 Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423 Calle, 2004, Obesity and cancer risk among white and black United States veterans, Cancer Causes Control, 15, 35, 10.1023/B:CACO.0000016573.79453.ba Moller, 1994, Obesity and cancer risk: a Danish record-linkage study, Eur J Cancer, 30A, 344, 10.1016/0959-8049(94)90254-2 Wolk, 2001, A prospective study of obesity and cancer risk (Sweden), Cancer Causes Control, 12, 13, 10.1023/A:1008995217664 Oh, 2005, Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study, J Clin Oncol, 23, 4742, 10.1200/JCO.2005.11.726 Pan, 2004, Association of obesity and cancer risk in Canada, Am J Epidemiol, 159, 259, 10.1093/aje/kwh041 Ahn, 1996, Strategy for vaccination against hepatitis B in areas with high endemicity: focus on Korea, Gut, 38, S63, 10.1136/gut.38.Suppl_2.S63 Nair, 2003, Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?, Hepatology, 36, 150, 10.1053/jhep.2002.33713 Adami, 1996, Excess risk of primary liver cancer in patients with diabetes mellitus, J Natl Cancer Inst, 89, 317 Yu, 1991, Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California, J Natl Cancer Inst, 83, 1820, 10.1093/jnci/83.24.1820 Wideroff, 1997, Cancer incidence in a population based cohort of patients hospitalized with diabetes mellitus in Denmark, J Natl Cancer Inst, 89, 1360, 10.1093/jnci/89.18.1360 Lagiou, 2000, Role of diabetes mellitus in the etiology of hepatocellular carcinoma, J Natl Cancer Inst, 92, 1096, 10.1093/jnci/92.13.1096 Hassan, 2002, Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus, Hepatology, 36, 1206, 10.1053/jhep.2002.36780 El-Serag, 2001, The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans, Am J Gastroenterol, 96, 2462, 10.1111/j.1572-0241.2001.04054.x Davila, 2005, Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study, Gut, 54, 533, 10.1136/gut.2004.052167 El-Serag, 2004, Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma, Gastroenterology, 126, 460, 10.1053/j.gastro.2003.10.065 Caldwell, 2004, Obesity and hepatocellular carcinoma, Gastroenterology, 127, S97, 10.1053/j.gastro.2004.09.021 Calle, 2004, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nat Rev Cancer, 4, 579, 10.1038/nrc1408 World Health Organization. Obesity epidemic puts millions at risk for related diseases [press release WHO/46]. Available at: http://www.who.int/archives/inf-pr-1997/en/pr97-46.html. IARC, 2002 Mokdad, 2003, Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001, JAMA, 289, 76, 10.1001/jama.289.1.76 Canman, 1995, Induction of apoptosis by tumor suppressor genes and oncogenes, Semin Cancer Biol, 6, 17, 10.1006/scbi.1995.0003 Leclerq, 2000, Leptin is required for the development of hepatic fibrosis, Hepatology, 32, 302A Yang, 2001, Hepatic hyperplasia in noncirrhotic fatty livers is obesity-related hepatic steatosis a premalignant condition?, Cancer Res, 61, 5016 Yang, 2000, Mitochondrial adaptations to obesity-related oxidant stress, Arch Biochem Biophys, 378, 259, 10.1006/abbi.2000.1829 Browning, 2004, Molecular mediators of hepatic steatosis and liver injury, J Clin Invest, 114, 147, 10.1172/JCI200422422 Loffreda, 1998, Leptin regulates proinflammatory immune responses, FASEB J, 12, 57, 10.1096/fasebj.12.1.57 Yu, 2003, Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis, Curr Mol Med, 3, 561, 10.2174/1566524033479537 Hu, 2000, The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutation hotspot in hepatocellular carcinoma, Carcinogenesis, 23, 1781, 10.1093/carcin/23.11.1781 Xu, 2005, Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia, Proc Natl Acad Sci U S A, 102, 4120, 10.1073/pnas.0500660102 Fang, 2004, Function of oval cells in hepatocellular carcinoma in rats, World J Gastroenterol, 10, 2482, 10.3748/wjg.v10.i17.2482 Li, 2003, Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells, World J Gastroenterol, 9, 1683, 10.3748/wjg.v9.i8.1683 Brakenhielm, 2004, Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis, Proc Natl Acad Sci U S A, 101, 2476, 10.1073/pnas.0308671100 Knight, 2005, Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta, Carcinogenesis, 26, 1782, 10.1093/carcin/bgi138 Ish-Shalom, 1997, Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor, Diabetologia, 40, S25, 10.1007/s001250051393 Chou, 1987, Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin, J Clin Invest, 79, 175, 10.1172/JCI112780 Alexia, 2004, An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis, Biochem Pharmacol, 68, 1003, 10.1016/j.bcp.2004.05.029 Tanaka, 2000, Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients, Cancer Res, 60, 5106 Rajala, 2003, Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis, Endocrinology, 144, 3765, 10.1210/en.2003-0580